Artificial Heart-Lung Machine Market Size Worth US$ 351.6 Million By 2028 | Growth Rate (CAGR) of 3.6%

Published April 25, 2023

IMARC Group’s latest report, titled “Artificial Heart-Lung Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on artificial heart-lung machine market report. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global artificial heart-lung machine market size reached US$ 282.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 351.6 Million by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028.

An artificial heart-lung machine also referred to as a cardiopulmonary bypass (CPB) or oxygenator pump, is utilized during coronary artery bypass, heart and lung transplants, and other cardiac surgeries. It momentarily executes the functions of the heart and lungs to allow the surgeon to work in a motion and bloodless surgical field. Artificial heart-lung machines comprise a chamber that receives blood, which is oxygenated and circulated to all body parts. Oxygenator pumps have assisted in making considerable advances in managing serious respiratory failure and in the field of cardiac surgeries. Consequently, these machines find extensive applications across hospitals and clinics.

Get a Free Sample Copy of this Report:

Market Trends:

The increasing incidences of cardiovascular diseases and organ failures, on account of numerous environmental and lifestyle changes, are among the key elements stimulating the artificial heart-lung machine market. Moreover, the launch of several policies by government bodies of various countries to provide improved healthcare facilities to patients is also propelling the market growth. Besides this, the growing investments by market players in research and development (R&D) activities to modernize the current models of oxygenator pumps are further fueling the global market. Furthermore, the escalating demand for modular heart-lung machines that are cost-effective, safe, and user-friendly in nature is acting as another significant growth-inducing factor. Apart from this, the rising usage of these machines offers flexibility to doctors, as they are portable and can be operated on rechargeable batteries, which is positively influencing the market growth. Additionally, the inflating improvements by manufacturers in CPB pumps to prevent the over-oxygenation of blood are anticipated to fuel the artificial heart-lung machine market over the forecasted period.

View Full Report with TOC & List of Figure:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Medtronic Inc
  • Sorin Group
  • MAQUET GmbH & Co. KG
  • Terumo Corporation
  • R. Bard Inc
  • Tianjin Medical
  • Edwards Lifesciences
  • Jarvik Heart
  • Braile Biomédica
  • SynCardia

Artificial Heart-Lung Machine Market Segmentation:

Our report has categorized the market based on region, type, application and end use industry.

Breakup by Type:

  • Single Roller Pump
  • Double Roller Pump

Breakup by Application:

  • Cardiac Surgeries
  • Lung Surgeries
  • Acute Respiratory Failure Treatment
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800